Skip to main content

Table 2 Odds ratio estimates for invasive infection using the generalized linear mixed-effects model (GLMM). n = 732 complete observations with 162 events. OR = odds ratio; CI = confidence interval; CCI = Charlson Comorbidity Index

From: Whole-genome sequence-informed MALDI-TOF MS diagnostics reveal importance of Klebsiella oxytoca group in invasive infections: a retrospective clinical study

  OR 95 % CI Z p value
K. oxytocagroupvs. K. pneumoniaegroup 2.39 [1.05,5.53] 2.01 0.044
K. oxytocavs.K. michiganensis 0.75 [0.42,1.34] − 0.97 0.33
K. oxytoca vs. K. grimontii 0.64 [0.30,1.36] − 1.15 0.252
K. pneumoniae vs. K. variicola 1.08 [0.69,1.65] 0.35 0.724
K. pneumoniae vs. K. quasipneumoniae 0.64 [0.35,1.15] − 1.44 0.149
CCI 1.14 [1.04,1.25] 2.95 0.003
Age (centred, 10 years increase) 0.84 [0.75,0.95] − 2.78 0.005
Female (ratio) 0.54 [0.37,0.79] − 3.17 0.002
Immunosuppression 0.5 [0.29,0.86] − 2.5 0.012
Resistance to 3rd-generation cephalosporins 1.31 [0.44,3.74] 0.5 0.618
Antibiotic treatment at entry or during hospitalization 3.11 [1.44,6.49] 2.92 0.003